What is allopurinol "failure" and what should we do about it?
Journal
The Journal of rheumatology
ISSN: 1499-2752
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984
Informations de publication
Date de publication:
15 Mar 2024
15 Mar 2024
Historique:
medline:
16
3
2024
pubmed:
16
3
2024
entrez:
15
3
2024
Statut:
aheadofprint
Résumé
Allopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "success" in gout management.
Identifiants
pubmed: 38490676
pii: jrheum.2024-0144
doi: 10.3899/jrheum.2024-0144
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM